FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097692 [Registered on: 19/11/2025] Trial Registered Prospectively
Last Modified On: 18/11/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda
Yoga & Naturopathy 
Study Design  Single Arm Study 
Public Title of Study   Can an Ayurveda-Based Digital Health Program help Improve Digestion, Metabolic Health, and Women’s Wellness in Adults?  
Scientific Title of Study   To Evaluate the Effectiveness of a Whole-System Medicine Approach-Based AIWeLL™ Protocol on Gastric, Metabolic & Women’s Disorders: A Single-Arm Pre-Post Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr R C Satish Kumar 
Designation  Ayurveda Doctor 
Affiliation  Bheshaja Ayurveda Clinic 
Address  82-B, Adhilakshmi Street,Rajeswari Nagar, Selaiyur,Chennai - 600073 (Road opposite to Pantaloons, Camp road signal)

Chennai
TAMIL NADU
600073
India 
Phone  9884845887  
Fax    
Email  ayursatish@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr R C Satish Kumar 
Designation  Ayurveda Doctor 
Affiliation  Bheshaja Ayurveda Clinic 
Address  82-B, Adhilakshmi Street,Rajeswari Nagar, Selaiyur,Chennai - 600073 (Road opposite to Pantaloons, Camp road signal)


TAMIL NADU
600073
India 
Phone  9884845887  
Fax    
Email  ayursatish@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr R C Satish Kumar 
Designation  Ayurveda Doctor 
Affiliation  Bheshaja Ayurveda Clinic 
Address  82-B, Adhilakshmi Street,Rajeswari Nagar, Selaiyur,Chennai - 600073 (Road opposite to Pantaloons, Camp road signal)


TAMIL NADU
600073
India 
Phone  9884845887  
Fax    
Email  ayursatish@gmail.com  
 
Source of Monetary or Material Support  
AYUR.AI PRIVATE LIMITED, GKS TECH PARK 2 , 4th Main Road, SIPCOT IT Park, Siruseri, off Old Mamallapuram Road, Chennai, Tamil Nadu 603103 
 
Primary Sponsor  
Name  AYUR.AI PRIVATE LIMITED 
Address  GKS TECH PARK 2 , 4th Main Road, SIPCOT IT Park, Siruseri, off Old Mamallapuram Road, Chennai, Tamil Nadu 603103 
Type of Sponsor  Other [Private company ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr R C Satish Kumar  Bheshaja Ayurveda Clinic  82-B, Adhilakshmi Street,Rajeswari Nagar, Selaiyur,Chennai - 600073 (Road opposite to Pantaloons, Camp road signal)
Chennai
TAMIL NADU 
9884845887

ayursatish@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr RK Diabetic Foot and Podiatry Institute & Rakesh Jhunjhunwala Amputation Prevention Center Institutional Ethics Committee (RKDF-IEC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Gastric Wellness Metabolic Wellness Women’s Wellness  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Sukumaram kashayam, Reference: Ashtangahridayam, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: Lukewarm water), Additional Information: -
(2) Medicine Name: Saptasaram kashayam, Reference: Sahasrayogam, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: Lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Adults aged 18–60 years, of any gender
2. Active smartphone users
3. Presence of non-severe, non-life-threatening health concerns related to gastric, metabolic, or women’s wellness.
4. Willingness to follow the prescribed Whole-System Medicine (WSM) protocol, including dietary, lifestyle, and mind-body interventions.
5. Ability to provide informed consent and comply with study procedures.
6. No surgical procedures or hospital admissions in the last six months
7. Occasional use of over-the-counter drugs or dietary supplements is allowed, provided they do not significantly affect primary outcomes. 
 
ExclusionCriteria 
Details  1. Who do not fall under the set cutoffs of Gastric, Metabolic, Women’s Wellness Group
2. Diagnosis of severe acute or chronic illness requiring urgent or intensive medical care.
3. Pregnant or breastfeeding women.
4. Use of immunosuppressive therapy or active malignancies.
5. History of major psychiatric disorders that may affect adherence to the intervention.
6. Participation in another clinical study within the past three months.
7. History of substance abuse (e.g., alcohol, tobacco, recreational drugs)
8. Occurrence of myocardial infarction, stroke, or angina within the last 3 months prior to enrolment.
9. Individuals with major diagnosed psychiatric disorders (e.g., depression, schizophrenia). 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
For Gastric wellness, Multi-Dimensional Gastrointestinal Symptom Severity Index (GISSI)
For Metabolic wellness, Waist circumference, BMI
For Women wellness, Women Health Questionnaire  
0th day, 60th day 
 
Secondary Outcome  
Outcome  TimePoints 
For Gastric wellness , CBC, URINE ROUTINE, LIVER FUNCTION TEST, AMYLASE, LIPASE, HS- CRP, VITAMIN B12, LIPID PROFILE

For Metabolic wellness, CBC, URINE ROUTINE, FASTING GLUCOSE, FASTING INSULIN, HBA1C, LIPID PROFILE, HS- CRP, APOLIPOPROTEINS (a1), APOLIPOPROTEINS (B), HOMOCYCTINE, RENAL FUNCTION TEST, LIVER FUNCTION TEST, VITAMIN B12, TFT

For women wellness - CBC, URINE ROUTINE, PROLACTIN, PROGESTERONE, ESTRADIOL, FSH, LH, DHEA-S, TESTOSTERONE TOTAL, FERRITIN, IRON, VITAMIN D, FASTING GLUCOSE, FASTING INSULIN, TFT, LIPID PROFILE

 
0th day, 60th day 
 
Target Sample Size   Total Sample Size="171"
Sample Size from India="171" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The increasing prevalence of chronic and lifestyle-related health conditions has highlighted the need for a comprehensive, patient-centred approach to well-being. Conventional medicine often addresses diseases in isolation, focusing on symptom management rather than holistic health optimization. Whole-System Medicine (WSM) is an integrative approach that considers multiple physiological, psychological, and lifestyle factors to improve overall health outcomes. This study aims to evaluate the effectiveness of a WSM-based intervention on well-being through a structured, stratified wellness protocol.


Research Question: Can a Whole-System Medicine approach, tailored to individual wellness needs (gastric, metabolic, and women’s wellness), improve health outcomes as measured by symptom-based assessments, biomarkers and gut microbiome composition?

Justification for the Study: There is a growing body of evidence suggesting that whole-system, integrative interventions encompassing nutrition, lifestyle modifications, personalized supplementation, and mind-body practices, can significantly improve health outcomes across various wellness domains. However, most existing research focuses on isolated interventions rather than a holistic, system-based methodology.

This study seeks to address this gap by providing robust evidence on the impact of a Whole-System Medicine approach using a single-arm pre-post design, assessing outcomes through symptoms, biomarkers and gut microbiome composition. By stratifying participants based on wellness needs, this study aims to offer targeted yet holistic interventions that align with personalized health optimization.
 
Close